Answers are grounded in this paper and cite their sources.
With widespread utilization of cross sectional imaging, the incidence of renal tumors continues to increase and tumors ≤4 cm comprise 48–66% of new renal cell carcinoma (RCC) diagnoses (1). The increased detection of small incidental tumors and technological improvements in surgery may lead to overtreatment of co-morbid patients with slow growing tumors (2).
No takes yet. Share an insight, caveat, or question.
Shapiro et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: